氧杂氮杂环丙烯
TL;DR: 氧杂氮杂环丙烯 (CAS 157-24-4) is a chemical compound with molecular formula CHNO and molecular weight 43.01 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
氧杂氮杂环丙烯
oxazirene
Also Known As: oxazirene, Oxazirine, RefChem:168857
| Molecular Formula | CHNO |
|---|---|
| Molecular Weight | 43.01 g/mol |
| LogP | -0.0401 |
| Topological Polar Surface Area | 24.89 Ų |
| Hydrogen Bond Donors | 0 |
| Hydrogen Bond Acceptors | 2 |
| Rotatable Bonds | 0 |
| Exact Mass | 43.005814 |
| Heavy Atoms | 3 |
| Complexity | 27.774437 |
Chemical Identifiers
| CAS Number | 157-24-4 |
|---|---|
| SMILES | C1=NO1 |
Product Overview
氧杂氮杂环丙烯 (CAS 157-24-4), with molecular formula CHNO and molecular weight 43.01 g/mol. IUPAC: oxazirene.
Chemical Property Profile of 氧杂氮杂环丙烯
Property Insights of 氧杂氮杂环丙烯
The XLogP value of -0.0401 indicates that 氧杂氮杂环丙烯 is hydrophilic (water-soluble), making it suitable for aqueous formulations and biological assay applications. With a topological polar surface area (TPSA) of 24.89 Ų, 氧杂氮杂环丙烯 exhibits relatively low polarity, potentially indicating favorable cell membrane permeability. Following Lipinski's Rule of Five, 氧杂氮杂环丙烯 has 0 hydrogen bond donor(s) and 2 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of 氧杂氮杂环丙烯?
The CAS number of 氧杂氮杂环丙烯 is 157-24-4.
What is the molecular formula of 氧杂氮杂环丙烯?
The molecular formula of 氧杂氮杂环丙烯 is CHNO.
What is the molecular weight of 氧杂氮杂环丙烯?
The molecular weight of 氧杂氮杂环丙烯 is 43.01 g/mol.
Where can I buy 氧杂氮杂环丙烯?
You can request a quote for 氧杂氮杂环丙烯 directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for 氧杂氮杂环丙烯?
Yes, KEHONG BIO provides custom synthesis services for 氧杂氮杂环丙烯 and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.